Vanguard Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.2B Buy
53,528,868
+167,094
+0.3% +$171M 1.37% 11
2026
Q1
$49.1B Buy
+53,361,774
New +$54.1B 1.21% 11

Other funds holding LLY

Vanguard Capital Management's LLY Position: Q2 2026 in Review

Vanguard Capital Management increased its Eli Lilly (LLY) stake by 0.31% in Q2 2026, buying an estimated $171M and bringing the position to 53,528,868 shares worth $64.2B. The position accounts for 1.37% of the portfolio, ranked #11.

Vanguard Capital Management first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vanguard Capital Management held 53,528,868 shares of Eli Lilly worth $64.2B as of Q2 2026.
  • Vanguard Capital Management bought 167,094 Eli Lilly shares in Q2 2026, an estimated $171M.
  • Eli Lilly made up 1.37% of Vanguard Capital Management's portfolio in Q2 2026, its #11 holding.
  • Vanguard Capital Management first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.